Systemic drug therapy of malignant pleural mesothelioma

Monaldi Archives for Chest Disease

Volumn 53, Issue 2, 1998, Pages 236-240

  Ardizzoni, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Clinical trials; Drug therapy; Malignant pleural mesothelioma

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYTOKINE; EPIPODOPHYLLOTOXIN; FOLIC ACID ANTAGONIST; MITOXANTRONE; OXAZAPHOSPHORINE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; VINCA ALKALOID;

CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONFERENCE PAPER; DISEASE COURSE; HUMAN; PLEURA MESOTHELIOMA; QUALITY OF LIFE;

EID: 0031829973     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Kane MJ, Chahinian AP, Holland JF. - Malignant mesothelioma in young adults. Cancer 1990; 65: 1449-1455.
2. Fusco V, Ardizzoni A, Merlo F, et al. - Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Anticancer Res 1993; 13: 683-690.